Loading...
BioCorRx Inc.
BICX•PNK
Healthcare
Medical - Care Facilities
$0.43
$0.002(0.40%)
BioCorRx Inc. (BICX) Financial Performance & Income Statement Overview
Review BioCorRx Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-91.40%
↓ 91.40%
Operating Income Growth
-35.24%
↓ 35.24%
Net Income Growth
-35.55%
↓ 35.55%
Operating Cash Flow Growth
40.85%
↑ 40.85%
Operating Margin
-2529.70%
↓ 2529.70%
Gross Margin
82.61%
↑ 82.61%
Net Profit Margin
-2340.41%
↓ 2340.41%
ROE
40.30%
↑ 40.30%
ROIC
76.65%
↑ 76.65%
BioCorRx Inc. (BICX) Income Statement & Financial Overview
Review BioCorRx Inc.'s (BICX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $4045.00 | $3620.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $35000.00 |
| Gross Profit | $0.00 | $0.00 | $4045.00 | -$31380.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $1.00 | -$8.67 |
| R&D Expenses | $272543.00 | $460138.00 | $536362.00 | $213834.00 |
| SG&A Expenses | $839193.00 | $1.19M | $830321.00 | $723478.00 |
| Operating Expenses | $1.12M | $1.66M | $1.37M | $937312.00 |
| Total Costs & Expenses | $1.12M | $1.66M | $1.37M | $972312.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $330183.00 | $307266.00 | $521456.00 | $368648.00 |
| Depreciation & Amortization | $22528.00 | $6714.00 | $23336.00 | $33333.00 |
| EBITDA | -$874922.00 | -$1.66M | -$689209.00 | -$835486.00 |
| EBITDA Ratio | -$170.39 | -$230.80 | ||
| Operating Income | -$1.12M | -$1.66M | -$1.37M | -$968690.00 |
| Operating Income Ratio | -$338.53 | -$267.59 | ||
| Other Income/Expenses (Net) | -$102893.00 | $146711.00 | $135356.00 | -$268771.00 |
| Income Before Tax | -$1.23M | -$1.51M | -$1.23M | -$1.24M |
| Income Before Tax Ratio | -$305.07 | -$341.84 | ||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$687.00 |
| Net Income | -$1.16M | -$1.49M | -$1.22M | -$1.24M |
| Net Income Ratio | -$300.95 | -$341.65 | ||
| EPS | $0.00 | -$0.14 | -$0.13 | -$0.14 |
| Diluted EPS | $0.00 | -$0.14 | -$0.13 | -$0.14 |
| Weighted Avg Shares Outstanding | $10.91M | $10.91M | $9.46M | $8.76M |
| Weighted Avg Shares Outstanding (Diluted) | $10.91M | $10.91M | $9.46M | $8.76M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan